Methods of treating graft versus host disease using IL-2 muteins
US12297248B2 · kind B2 · utility
0Cited by
16References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 2022 |
| Grant date | May 13, 2025 |
| Priority date | — |
| Expiry date | Jun 4, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are immunosuppressive molecules including immunosuppressive variants of IL-2, and use of such molecules to treat inflammatory and autoimmune disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.